UPDATED May 16, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FDE | €37.80 | 7.1% | -1.2% | €197.7m | €64.07 | PE25.1x | E37.6% | n/a | Energy | ||
OSE | €7.54 | 11.7% | 99.5% | €162.6m | €7.15 | PS73x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €9.60 | 11.2% | 168.9% | €138.1m | €9.70 | PS22.8x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €19.32 | 0% | -14.5% | €159.6m | €30.30 | PE21x | E37.7% | n/a | Capital Goods | ||
VU | €161.70 | 3.1% | 5.1% | €2.6b | €190.17 | PE32.3x | E25.8% | 0% | Tech | ||
ALLIX | €8.46 | -4.5% | -40.7% | €54.7m | €16.50 | PS1.6x | E101.4% | n/a | Software | ||
ALMUN | €0.53 | -6.4% | -82.0% | €4.8m | €1.30 | PB0.4x | E150.0% | n/a | Tech | ||
ALCUR | €6.56 | -3.0% | 133.5% | €37.8m | €7.48 | PE21x | E41.7% | n/a | Capital Goods | ||
ALICA | €9.94 | 1.2% | -41.2% | €80.4m | €16.00 | PE14.7x | E26.1% | 2.0% | Tech | ||
MEDCL | €13.70 | -8.1% | 102.7% | €393.9m | €19.24 | PS27.9x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
S30 | €2.26 | 5.1% | -21.6% | €242.3m | €2.75 | PB2.2x | E99.8% | n/a | Software | ||
ALHOP | €20.40 | -1.0% | 17.2% | €53.8m | €30.05 | PE11.8x | E21.5% | 3.2% | Media | ||
ALCIS | €8.92 | -3.9% | -0.9% | €69.5m | €12.10 | PE21.8x | E56.2% | 1.8% | Commercial Services | ||
OVH | €6.50 | 6.0% | -37.0% | €1.2b | €11.35 | PS1.3x | E101.5% | n/a | Software | ||
LSS | €33.75 | 1.7% | 16.0% | €1.3b | €37.13 | PE38.2x | E28.6% | 1.1% | Software | ||
ALLPL | €0.95 | 0% | -67.2% | €11.5m | €2.00 | PB3.3x | E97.3% | n/a | Consumer Services | ||
CLA | €2.31 | -2.3% | 17.0% | €130.8m | €4.75 | PE-26.2x | E90.3% | n/a | Software | ||
ALFRE | €3.32 | -0.3% | -40.8% | €186.4m | €5.30 | PE12.9x | E22.7% | 2.4% | Commercial Services | ||
ALPAT | €15.20 | 6.3% | 13.4% | €16.5m | €11.50 | PS7.1x | E92.7% | n/a | Pharmaceuticals & Biotech | ||
BLV | €15.00 | 0% | 22.1% | €1.5b | €17.31 | PS1.7x | E74.2% | n/a | Media | ||
ALECP | €0.38 | 11.8% | -29.4% | €46.8m | n/a | PS1.2x | E210.6% | 0% | Media |